Literature DB >> 25378353

Intraocular levels of interleukin 17A (IL-17A) and IL-10 as respective determinant markers of toxoplasmosis and viral uveitis.

Arnaud Sauer1, Odile Villard2, Catherine Creuzot-Garcher3, Christophe Chiquet4, Jean-Paul Berrod5, Claude Speeg-Schatz6, Tristan Bourcier6, Ermanno Candolfi2.   

Abstract

Uveitis is a potentially blinding inflammatory disease. Thirty to 50% of uveitis cases are considered idiopathic. The present study sought to determine the intraocular cytokine patterns in the different etiological types of uveitis in order to better understand their immunological regulation and to determine whether the cytokine pattern may be a useful diagnostic tool. From a multicenter institutional prospective study, the clinical and biological data from patients with uveitis of various etiologies, determined after a complete workup, were compared with those from a control group of cataract patients. A multiplex assay was used to assess the profiles of 27 cytokines and chemokines in aqueous humor samples from these patients. In total, 62 patients with infectious or noninfectious uveitis and 88 controls were included. After a complete workup, the cause of uveitis remained unknown in 25 patients (40% idiopathic uveitis). Interleukin 1β (IL-1β) levels were markedly increased in viral uveitis, as were IL-10 levels, whereas IL-17A levels were augmented in toxoplasmic uveitis. Based on the cytokine pattern, the patients were reassigned to specific groups. At the end of the study, the diagnosis of idiopathic uveitis was still valid in only 11 patients (18%). The observation that some markers are specific to certain diseases enables a better understanding of the disease pathogenesis and paves the way for new diagnostic methods aimed to identify inflammatory markers, which may perhaps be targeted by therapy.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25378353      PMCID: PMC4278934          DOI: 10.1128/CVI.00423-14

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  35 in total

1.  Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center.

Authors:  B Bodaghi; N Cassoux; B Wechsler; D Hannouche; C Fardeau; T Papo; D L Huong; J C Piette; P LeHoang
Journal:  Medicine (Baltimore)       Date:  2001-07       Impact factor: 1.889

Review 2.  Emergence of the Th17 pathway and its role in host defense.

Authors:  Darrell B O'Quinn; Matthew T Palmer; Yun Kyung Lee; Casey T Weaver
Journal:  Adv Immunol       Date:  2008       Impact factor: 3.543

Review 3.  Biologic therapies in non-rheumatic diseases: lessons for rheumatologists?

Authors:  Gillian M Bell; Gary Reynolds; John D Isaacs
Journal:  Nat Rev Rheumatol       Date:  2011-08-02       Impact factor: 20.543

Review 4.  Understanding uveitis: the impact of research on visual outcomes.

Authors:  Marc D de Smet; Simon R J Taylor; Bahram Bodaghi; Elisabetta Miserocchi; Philip I Murray; Uwe Pleyer; Manfred Zierhut; Talin Barisani-Asenbauer; Phuc LeHoang; Sue Lightman
Journal:  Prog Retin Eye Res       Date:  2011-07-22       Impact factor: 21.198

5.  TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1.

Authors:  Ahjoku Amadi-Obi; Cheng-Rong Yu; Xuebin Liu; Rashid M Mahdi; Grace Levy Clarke; Robert B Nussenblatt; Igal Gery; Yun Sang Lee; Charles E Egwuagu
Journal:  Nat Med       Date:  2007-05-13       Impact factor: 53.440

6.  Herpes simplex virus remodels T-cell receptor signaling, resulting in p38-dependent selective synthesis of interleukin-10.

Authors:  Derek D Sloan; Keith R Jerome
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

Review 7.  Immune responses against persistent viral infections: possible avenues for immunotherapeutic interventions.

Authors:  Shinichiro Fuse; Michael J Molloy; Edward J Usherwood
Journal:  Crit Rev Immunol       Date:  2008       Impact factor: 2.214

8.  Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV.

Authors:  Shahram Salek-Ardakani; John R Arrand; Mike Mackett
Journal:  Virology       Date:  2002-12-20       Impact factor: 3.616

9.  Cytokine profiles in toxoplasmic and viral uveitis.

Authors:  Ibtissem Lahmar; Ahmed Abou-Bacar; Tamer Abdelrahman; Marie Guinard; Hamouda Babba; Salim Ben Yahia; Moncef Kairallah; Claude Speeg-Schatz; Tristan Bourcier; Arnaud Sauer; Odile Villard; Alexander W Pfaff; Marc Mousli; Justus G Garweg; Ermanno Candolfi
Journal:  J Infect Dis       Date:  2009-04-15       Impact factor: 5.226

View more
  13 in total

Review 1.  Ocular diseases: immunological and molecular mechanisms.

Authors:  Jing Song; Yi-Fei Huang; Wen-Jing Zhang; Xiao-Fei Chen; Yu-Mian Guo
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

Review 2.  Cytokines in uveitis.

Authors:  Jessica E Weinstein; Kathryn L Pepple
Journal:  Curr Opin Ophthalmol       Date:  2018-05       Impact factor: 3.761

3.  Primate neural retina upregulates IL-6 and IL-10 in response to a herpes simplex vector suggesting the presence of a pro-/anti-inflammatory axis.

Authors:  Monica M Sauter; Curtis R Brandt
Journal:  Exp Eye Res       Date:  2016-05-08       Impact factor: 3.467

4.  Intraocular cytokines imbalance in congenital cataract and its impact on posterior capsule opacification.

Authors:  Arnaud Sauer; Tristan Bourcier; David Gaucher; Ermanno Candolfi; Claude Speeg-Schatz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-03-12       Impact factor: 3.117

Review 5.  Roles of interleukin-17 in uveitis.

Authors:  Marta Catarina Esteves Guedes; Luis Miguel Borrego; Rui Daniel Proença
Journal:  Indian J Ophthalmol       Date:  2016-09       Impact factor: 1.848

6.  Personalized Proteomics for Precision Health: Identifying Biomarkers of Vitreoretinal Disease.

Authors:  Gabriel Velez; Peter H Tang; Thiago Cabral; Galaxy Y Cho; Daniel A Machlab; Stephen H Tsang; Alexander G Bassuk; Vinit B Mahajan
Journal:  Transl Vis Sci Technol       Date:  2018-09-26       Impact factor: 3.283

7.  Immune Mediator Profile in Aqueous Humor Differs in Patients with Primary Acquired Ocular Toxoplasmosis and Recurrent Acute Ocular Toxoplasmosis.

Authors:  Claudia Thieme; Stephan Schlickeiser; Sylvia Metzner; Claudia Dames; Uwe Pleyer
Journal:  Mediators Inflamm       Date:  2019-02-17       Impact factor: 4.711

Review 8.  Interleukins and cytokine biomarkers in uveitis.

Authors:  S Balamurugan; Dipankar Das; Murat Hasanreisoglu; Brian C Toy; Mashal Akhter; V K Anuradha; Eliza Anthony; Bharat Gurnani; Kirandeep Kaur
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

9.  Murine Model of Primary Acquired Ocular Toxoplasmosis: Fluorescein Angiography and Multiplex Immune Mediator Profiles in the Aqueous Humor.

Authors:  Kexin Li; Xue Feng; Kenji Hikosaka; Kazumi Norose
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-03-01       Impact factor: 4.799

Review 10.  Immunomodulation with IL-17 and TNF-α in spondyloarthritis: focus on the eye and the central nervous system.

Authors:  Elsa How Shing Koy; Pierre Labauge; Athan Baillet; Clément Prati; Hubert Marotte; Yves-Marie Pers
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-07-09       Impact factor: 5.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.